Companies Dominating the Non-Hodgkin Lymphoma Therapeutics Market
- AbbVie, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GSK plc.
- Novartis AG
- Bayer AG
- Bausch Health Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- SIRPant Immunotherapeutics Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Non-Hodgkin Lymphoma Therapeutics Market in 2025 is estimated at USD 10.7 billion.
The global market size was valued at more than USD 10.07 billion in 2024 and is expected to register a CAGR of over 7.8%, exceeding USD 26.73 billion revenue by 2037.
North America is forecast to record USD 8.02 billion by 2037, fueled by advancements in AI and healthcare technologies.
The major players in the market include AbbVie, Inc., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc. are.
